In vitro analysis of aminoglycoside therapy for the Arg120stop nonsense mutation in RP2 patients.
Grayson
C
C
Chapple
J P
JP
Willison
K R
KR
Webster
A R
AR
Hardcastle
A J
AJ
Cheetham
M E
ME
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001120:Arginine / Q000235:genetics*; D016466:CHO Cells; D002460:Cell Line; D018389:Codon, Nonsense / Q000235:genetics*; D006224:Cricetinae; D005136:Eye Proteins; D019204:GTP-Binding Proteins; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D008565:Membrane Proteins; D011506:Proteins / Q000235:genetics*; D012174:Retinitis Pigmentosa / Q000188:drug therapy* / Q000235:genetics*
D000900:Anti-Bacterial Agents; D018389:Codon, Nonsense; D005136:Eye Proteins; D005839:Gentamicins; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D011506:Proteins; C072178:RP2 protein, human; D001120:Arginine; D019204:GTP-Binding Proteins